Role of Transcranial Direct Current Stimulation (tDCS) in Patients With Attention Deficit Hyperactivity Disorder (ADHD)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Attention Deficit Hyperactivity Disorder
- Sponsor
- Hospital de Clinicas de Porto Alegre
- Enrollment
- 16
- Locations
- 1
- Primary Endpoint
- Change in scores obtained in ASRS scale.
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
The purpose of this study is to determine whether transcranial direct current stimulation (tDCS) is effective in the treatment attention deficit hyperactivity disorder (ADHD).
Randomized, double-blind Controlled Clinical Trial
Subjects Adults (between 18 and 59 years of age) with ADHD who meet the inclusion criteria and who agree to participate in the study Will recruit from advertisements and clinical referrals to a PRODAH
Active tDCS Anode - right DLPFC Cathode - left DLPFC Electric current is 2mA - Current is applied for 20 min
Sham tDCS Same assembly is used Current is applied for 30 sec
Both groups 5 stimulation sessions on consecutive days
Following tools at Baseline, 1st week, 2 st week, 3st week and 4st week Adult ADHD Self-Report Scale (ASRS) SDS - Sheehan Disability Scale CGI - Clinical Global Impression
Detailed Description
Randomized, double-blind Controlled Clinical Trial Subjects Adults (between 18 and 59 years of age) with ADHD who meet the inclusion criteria and who agree to participate in the study Will recruit from advertisements and clinical referrals to a PRODAH Active tDCS Anode - right DLPFC Cathode - left DLPFC Electric current is 2mA - Current is applied for 20 min Sham tDCS Same assembly is used Current is applied for 30 sec Both groups 5 stimulation sessions on consecutive days Following tools at Baseline, 1st week, 2 st week, 3st week and 4st week Adult ADHD Self-Report Scale (ASRS) SDS - Sheehan Disability Scale CGI - Clinical Global Impression
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age between 18 to 45 years
- •Established diagnosis of ADHD according to DSM V through clinical interview and diagnostic criteria applied by trained physicians.
- •ASRS greater than 21 in Part A or B
- •Consent form signed
- •Ability to read and interpret the self-applicable scales
Exclusion Criteria
- •Medication change in the last month
- •The following comorbidities:
- •Depressive episode with BDI greater than 9
- •Anxiety Disorder with greater than 15 BAI
- •Bipolar Disorder with depressive symptoms, manic or hypomanic in the last 6 months
- •Schizophrenia and other psychotic disorders
- •dependence of substances
- •Mental retardation or dementia
- •Epilepsy or anticonvulsant use
- •Clinically significant medical condition
Outcomes
Primary Outcomes
Change in scores obtained in ASRS scale.
Time Frame: Autcome measure assesments: day 1 (pre-intervention), day 5 (post-intervention), 1 and 4 weeks later (accompaniment).
This scale is used to access symptoms improvement in ADHD patients, is a self repor scale.
Secondary Outcomes
- Change in scores obtained in CGI scale.(Autcome measure assesments: day 1 (pre-intervention), day 5 (post-intervention), 1 and 4 weeks later (accompaniment).)
- Change in scores obtained in Sheehan disability scale(Autcome measure assesments: day 1 (pre-intervention), day 5 (post-intervention), 1 and 4 weeks later (accompaniment).)